Detection of Trichophyton spp. from footwear of patients with tinea pedis.


Journal

Drug discoveries & therapeutics
ISSN: 1881-784X
Titre abrégé: Drug Discov Ther
Pays: Japan
ID NLM: 101493809

Informations de publication

Date de publication:
2019
Historique:
entrez: 20 9 2019
pubmed: 20 9 2019
medline: 6 2 2020
Statut: ppublish

Résumé

The prevalence of tinea pedis (also known as athlete's foot) in Japanese workers as well as contamination of their footwear by pathogenic filamentous fungi were investigated. Health checks by a dermatologist at a factory located in the Kanto region (Japan) led to a clinical and morphologic diagnosis of tinea pedis in 9 of 19 workers. Scales obtained from the feet and dust obtained from the protective footwear (safety shoes) worn daily in the factory were obtained from these nine subjects and tested using a mycological culture technique. Scales obtained from six of the nine subjects indicated pathogenic filamentous fungi, not only Trichophyton spp., but also Acremonium, which causes symptoms similar to tinea pedis or onychomycosis. Similarly, culture of the dust obtained from the safety shoes yielded pathogenic filamentous fungi in six of the nine subjects, and in four samples Trichophyton spp. was also identified. These findings suggest that cultivable Trichophyton spp. can be detected in approximately 40% of the safety shoes of workers with tinea pedis. The risk of reinfection by pathogenic filamentous fungi is likely increased by wearing dermatophyte-contaminated shoes.

Identifiants

pubmed: 31534072
doi: 10.5582/ddt.2019.01060
doi:

Substances chimiques

DNA, Fungal 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

207-211

Auteurs

Sanae A Ishijima (SA)

Teikyo University Institute of Medical Mycology.

Masataro Hiruma (M)

Hiruma Clinic.

Kazuhisa Sekimizu (K)

Teikyo University Institute of Medical Mycology.

Shigeru Abe (S)

Teikyo University Institute of Medical Mycology.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH